Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Feb 6, 2023
Date Accepted: Nov 29, 2023

The final, peer-reviewed published version of this preprint can be found here:

Timing, Indicators, and Approaches to Digital Patient Experience Evaluation: Umbrella Systematic Review

Wang T, Giunti G, Goossens R, Melles M

Timing, Indicators, and Approaches to Digital Patient Experience Evaluation: Umbrella Systematic Review

J Med Internet Res 2024;26:e46308

DOI: 10.2196/46308

PMID: 38315545

PMCID: 10877490

Evaluating the Digital Patient Experience: Timing, Indicators, and Approaches Based on an Umbrella Systematic Review

  • Tingting Wang; 
  • Guido Giunti; 
  • Richard Goossens; 
  • Marijke Melles

ABSTRACT

Background:

Despite the growing number of digital health (DH) applications, timely, cost-effective, and robust evaluations have not kept pace. Patient experience (PEx) was reported as one of the challenges facing the health system by the World Health Organization (WHO) in its 2018 classification of digital health initiatives report. To generate evidence of DH and promote the appropriate integration and use of technologies, standard evaluation of PEx in DH is needed.

Objective:

In this study, we systematically reviewed the literature on PEx evaluation timing considerations, evaluation indicators, and evaluation approaches in DH and generated an evaluation guide for further measurement of PEx in DH.

Methods:

We performed an umbrella systematic review following PRISMA, searching Scopus, PubMed, and Web of Science databases. Two rounds of small random sampling (20%) were independently reviewed by two reviewers who evaluated the eligibility of the articles against the selection criteria. Two-round interrater reliability was assessed using the Fleiss-Cohen coefficient (k1=0.88 and k2=0.80). Thematic analysis was then applied to analyze the extracted data based on a set of a priori categories.

Results:

The search yielded 173 records, of which 45 (26%) were eligible for analysis. Our review highlights five typical evaluation objectives which serve five stakeholder groups separately. We identified three evaluation timing considerations and classified them into three categories: intervention maturity stages, timing of the evaluation, and timing of data collection. Information on evaluation indicators of the digital PEx was identified and summarized into 3 categories (intervention outputs, patient outcomes, and healthcare system impact), 9 themes, and 22 subthemes. A set of evaluation theories, common study designs, data collection methods and instruments, and data analysis approaches were captured which can be used or adapted to evaluate the digital PEx.

Conclusions:

Our findings enabled us to generate an evaluation guide to help digital health interventions (DHI) researchers, designers, developers, and program evaluators to evaluate the digital PEx. Finally, we propose six directions for encouraging further digital PEx evaluation research and practice to address the poor PEx challenge.


 Citation

Please cite as:

Wang T, Giunti G, Goossens R, Melles M

Timing, Indicators, and Approaches to Digital Patient Experience Evaluation: Umbrella Systematic Review

J Med Internet Res 2024;26:e46308

DOI: 10.2196/46308

PMID: 38315545

PMCID: 10877490

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.